Diabetes Outcomes and Unmet Resources
Improving Diabetes Outcomes and Health Disparities Through a Patient Activation Intervention Addressing Unmet Resource Needs
2 other identifiers
interventional
667
1 country
1
Brief Summary
This study will refine and test the effectiveness of CareAvenue, an automated e-health tool that informs and activates patients with uncontrolled diabetes to take steps in accessing resources and engaging in self-care. Our central hypothesis is that activating patients with uncontrolled diabetes and linking them to resources to address financial burden and unmet social risk factors will improve both intermediate outcomes and measures of disease control above and beyond existing services, especially for high need patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes
Started Jun 2019
Longer than P75 for not_applicable diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 13, 2019
CompletedFirst Posted
Study publicly available on registry
May 15, 2019
CompletedStudy Start
First participant enrolled
June 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 28, 2023
CompletedResults Posted
Study results publicly available
May 2, 2024
CompletedMay 2, 2024
April 1, 2024
3.8 years
May 13, 2019
March 3, 2024
April 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in HbA1c as Measured by an HbA1c Machine
HbA1c will be measured at baseline, 6 months, and 12 months using HbA1c machine. HbA1c is a measure of the average level of glucose in blood over the past 3 months measured as a percentage. The change in HbA1c from baseline to 12 months is reported here as the primary outcome.
Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)
Secondary Outcomes (6)
Change in Systolic Blood Pressure as Measured an Automated Blood Pressure Machine
Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)
Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Diabetes as Measured by Participant Questionnaire
Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)
Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Other Conditions Being Managed as Measured by Participant Questionnaire
Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)
Change in Perceived Financial Burden as Measured by the Comprehensive Score for Financial Toxicity (COST) - Functional Assessment of Chronic Illness Therapy (FACIT)
Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)
Change in Unmet Social Risk Factors as Measured by 20 Items in Participant Questionnaire
Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)
- +1 more secondary outcomes
Study Arms (2)
CareAvenue
EXPERIMENTALParticipants receive access to CareAvenue, an e-health tool, and receive one weekly automated telephone call and 4-5 text messages per week for 52 weeks.
Guest Assistance Program
ACTIVE COMPARATORParticipants receive information about the Guest Assistance Program (GAP) and receive 3-4 text messages per week related to diabetes management and resources for 52 weeks.
Interventions
CareAvenue is an e-health tool providing information about diabetes management and low-cost resources. Participants in this group have access to CareAvenue and receive a weekly automated phone call and text messages related to CareAvenue and its resources as well as diabetes management.
The Guest Assistance Program (GAP) is a resource, which provides assistance with medical and non-medical needs and resources to patients receiving medical care at University of Michigan health system. Participants in this group are provided with GAP information and receive text messages related to diabetes management.
Eligibility Criteria
You may qualify if:
- Be 18-75 years of age
- Be diagnosed with type 1 or type 2 diabetes with prescribed anti-hyperglycemic medication
- Have a most recent hemoglobin A1c(HbA1c) level within the past 6 months of ≥7.5% for individuals ≤70 years and \>8.0% for individuals between 70-75 years in age
- Have access to a telephone that can receive and send text messages
- Not participating in another diabetes intervention research study
You may not qualify if:
- Significant cognitive impairment precluding individuals from completing the study as evidenced by ability to complete study intake procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
Related Publications (2)
Patel MR, Zhang G, Heisler M, Piette JD, Resnicow K, Choe HM, Shi X, Song P. A Randomized Controlled Trial to Improve Unmet Social Needs and Clinical Outcomes Among Adults with Diabetes. J Gen Intern Med. 2024 Oct;39(13):2415-2424. doi: 10.1007/s11606-024-08708-8. Epub 2024 Mar 11.
PMID: 38467918DERIVEDPatel MR, Heisler M, Piette JD, Resnicow K, Song PXK, Choe HM, Shi X, Tobi J, Smith A. Study protocol: CareAvenue program to improve unmet social risk factors and diabetes outcomes- A randomized controlled trial. Contemp Clin Trials. 2020 Feb;89:105933. doi: 10.1016/j.cct.2020.105933. Epub 2020 Jan 7.
PMID: 31923472DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Minal R. Patel, Ph.D, M.P.H
- Organization
- University of Michigan School of Public Health, Department of Health Behavior & Health Education
Study Officials
- PRINCIPAL INVESTIGATOR
Minal R Patel, PhD, MPH
University of Michigan
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 13, 2019
First Posted
May 15, 2019
Study Start
June 26, 2019
Primary Completion
March 28, 2023
Study Completion
March 28, 2023
Last Updated
May 2, 2024
Results First Posted
May 2, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP, ANALYTIC CODE
- Time Frame
- Beginning 3 months and ending 5 years following article publication
- Access Criteria
- The data will be made available to other researchers who provide a methodologically sound proposal and who have appropriate approvals from all relevant IRBs. The data will be shared for analyses to achieve aims in the approved proposal. Data will be shared through a secure FTP site through encryption protocols that allow secure uploading of files with data sharing limited to specific users. Select datasets will also be made available through the University of Michigan openICPSR Repository (http://www.icpsr.umich.edu/icpsrweb/deposit/index.jsp). Proposals should be directed to minalrp@umich.edu. To gain access, data requestors will need to sign a data access agreement.
All of the individual participant data that underlie results in a publication, after de-identification.